2 insiders reported 10 Form 4 transactions for TScan Therapeutics, Inc. (TCRX) over the past 18 months (most recent 2025-12-23). Recent activity: Lynx1 Capital Management LP (10% Owner) Buy 75,500 shares, Lynx1 Capital Management LP (10% Owner) Buy 80,069 shares, Nichols Weston (10% Owner) Buy 75,500 shares, Nichols Weston (10% Owner) Buy 80,069 shares, Nichols Weston (10% Owner) Buy 6,232 shares. Source: SEC Form 4.
| Date | Insider | Title | Type | Shares | Value |
|---|---|---|---|---|---|
| 2025-12-23 | Lynx1 Capital Management LP | 10% Owner | Buy | 75,500 | $67,950 |
| 2025-12-23 | Lynx1 Capital Management LP | 10% Owner | Buy | 80,069 | $72,062 |
| 2025-12-23 | Nichols Weston | 10% Owner | Buy | 75,500 | $67,950 |
| 2025-12-23 | Nichols Weston | 10% Owner | Buy | 80,069 | $72,062 |
| 2025-12-23 | Nichols Weston | 10% Owner | Buy | 6,232 | $5,609 |
| 2025-12-23 | Lynx1 Capital Management LP | 10% Owner | Buy | 6,232 | $5,609 |
| 2025-05-21 | Nichols Weston | 10% Owner | Buy | 1.4M | $1.7M |
| 2025-05-21 | Lynx1 Capital Management LP | 10% Owner | Buy | 1.4M | $1.7M |
| 2025-05-21 | Nichols Weston | 10% Owner | Buy | 1.2M | $1.4M |
| 2025-05-21 | Lynx1 Capital Management LP | 10% Owner | Buy | 1.2M | $1.4M |
Source: SEC Form 4 filings · as of 2025-12-23